查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750805

醫藥運輸服務市場規模、佔有率、趨勢分析報告：按類型、服務、供應鏈、地區、細分市場預測，2025-2030 年

Pharmaceutical Transportation Services Market Size, Share & Trends Analysis Report By Type (Biopharmaceuticals, Pharmaceuticals), By Service (Air Freight, Sea Freight, Overland), By Supply Chain, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

醫藥運輸服務市場成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球醫藥運輸服務市場規模預計到2030年將達到1,248.1億美元，2025年至2030年的複合年成長率為7.71%。

該市場的成長主要歸因於對溫度敏感藥物的需求不斷增加、醫藥供應鏈的擴大以及嚴格指導方針的實施。

生技藥品、疫苗以及細胞和基因療法的日益普及，正在對醫藥運輸服務市場產生正面影響。與傳統的小分子藥物不同，生技藥品對溫度變化和物理處理高度敏感，需要嚴格的低溫運輸物流來維持產品完整性。這種需求推動了專用冷藏車、冷藏倉庫和包裝解決方案的普及，以確保在整個運輸過程中不間斷地控制溫度。包括新冠疫苗分發在內的大規模疫苗接種計劃的開展，證明了溫控運輸的重要性，並加速了對低溫運輸基礎設施的投資。

此外，製藥公司擴大將生產和分銷業務外包給合約開發與受託製造廠商(CDMO) 和物流合作夥伴，進一步擴展了全球供應鏈。這些複雜的網路跨越多個地區，需要可靠、安全、及時且符合國際和當地監管標準的運輸服務。一種藥品的組件可能在一個國家生產，在另一個國家組裝，並分銷到多個市場，因此需要同步的物流規劃。隨著生產日益分散，對精通清關、文件處理和多式聯運的第三方物流供應商 (3PL) 的依賴性也日益增強。此外，亞太、拉丁美洲和東歐等新興市場已成為重要的生產和消費樞紐，增加了國際藥品運輸的頻率和數量。

此外，包括 DHL、UPS Healthcare、FedEx Express 和 Kuehne+Nagel 在內的幾家主要競爭對手正在積極透過策略性投資、合作夥伴關係和技術採用來擴展其能力，以擴大其市場佔有率。為了應對日益成長的低溫運輸物流需求，這些公司正在努力增強其基礎設施和服務產品。例如，2025 年 4 月，DHL 向健康物流投資 22.7 億美元，以根據其 2030 策略加強其生命科學和醫療物流。一半的投資針對美國，其餘投資則分配給亞太地區和歐洲、中東和非洲地區，以擴展其全球基礎設施。此舉加強了 DHL 作為提供以患者為中心的綜合醫藥運輸解決方案的主要競爭對手的地位。

醫藥運輸服務市場報告重點

  • 根據類型，生物製藥領域在 2024 年佔據了市場主導地位。該領域的成長主要歸因於對能夠處理生技藥品、基因治療藥物和個人化藥物的高效、安全、合規的運輸解決方案的需求不斷成長。
  • 按服務分類，航空貨運領域在 2024 年佔據了市場主導地位。該領域的成長主要歸因於對高價值、時間敏感和溫控藥品快速交付的需求不斷成長。
  • 按供應鏈分類，非低溫運輸物流領域在 2024 年佔據了市場主導地位。該領域的成長受到醫療設備、非處方藥 (OTC) 和學名藥分銷需求不斷成長的推動。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章醫藥運輸服務市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 相關/輔助市場展望。
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 技術格局
  • 定價模式分析
  • 產業市場分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章：醫藥運輸服務市場：按類型估計和趨勢分析

  • 細分儀表板
  • 全球醫藥運輸服務市場趨勢分析（按類型）
  • 全球醫藥運輸服務市場規模及趨勢分析（按類型，2018-2030）
  • 生物製藥
    • 疫苗
    • 生物相似藥
    • 血漿衍生產品
    • 其他
  • 製藥

第5章：醫藥運輸服務市場：依服務估算與趨勢分析

  • 細分儀表板
  • 全球醫藥運輸服務市場服務變化分析
  • 全球醫藥運輸服務市場規模及趨勢分析（依服務，2018-2030）
  • 空運
  • 海運
  • 陸上

第6章醫藥運輸服務市場：供應鏈的估計與趨勢分析

  • 細分儀表板
  • 全球醫藥運輸服務市場供應鏈波動分析
  • 全球醫藥運輸服務市場規模及趨勢分析（依供應鏈，2018-2030）
  • 低溫運輸物流
  • 非低溫運輸物流

第7章醫藥運輸服務市場：區域估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 挪威
    • 瑞典
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 競爭性分類
  • 2024 年公司市場佔有率/估值分析
  • 公司簡介
    • CEVA Logistics
    • Cencora Corporation（ICS）
    • DB SCHENKER
    • Kuehne+Nagel
    • Kerry Logistics Network Limited
    • Cardinal Health
    • FedEx
    • McKesson Corporation
    • DHL
    • EVERSANA
    • Thermo Fisher Scientific
    • Knipper Health
Product Code: GVR-4-68040-581-6

Pharmaceutical Transportation Services Market Growth & Trends:

The global pharmaceutical transportation services market size is expected to reach USD 124.81 billion by 2030, registering a CAGR of 7.71% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is mainly due to increasing demand for temperature sensitive drugs, expansion of pharmaceutical supply chain, and implementation of stringent guideline.

The growing use of biologics, vaccines, and cell and gene therapies has positively impacted the pharmaceutical transportation services market. Unlike conventional small-molecule drugs, biologics are highly sensitive to temperature variations and physical handling, requiring strict cold chain logistics to maintain product integrity. This demand has led to the proliferation of specialized refrigerated vehicles, cold storage warehouses, and packaging solutions that ensure uninterrupted temperature control throughout the shipping process. The rollout of large-scale vaccination programs, including COVID-19 vaccine distribution, demonstrated the critical importance of temperature-controlled transport and accelerated investment in cold chain infrastructure.

Furthermore, the pharmaceutical companies are increasingly outsourcing manufacturing and distribution activities to contract development and manufacturing organizations (CDMOs) and contract logistics partners, further expanding global supply chains. These complex networks span across regions, creating a need for reliable, secure, and timely transportation services that meet both international and local regulatory standards. Drug components may be produced in one country, assembled in another, and distributed across multiple markets, necessitating synchronized logistics planning. As production decentralizes, the reliance on third-party logistics providers (3PLs) with expertise in navigating customs, documentation, and multi-modal transport has increased. Furthermore, emerging markets in Asia-Pacific, Latin America, and Eastern Europe have become important hubs for both manufacturing and consumption, increasing the frequency and volume of international pharmaceutical shipments.

Furthermore, several key competitors in the market, such as DHL, UPS Healthcare, FedEx Express, and Kuehne+Nagel, are actively expanding capabilities through strategic investments, partnerships, and technology adoption to gain market share. The rising demand for cold chain logistics has led these players to enhance their infrastructure and service offerings. For instance, in April 2025, DHL invested USD 2.27 billion in health logistics to strengthen its life sciences and healthcare logistics, aligning with its "Strategy 2030." Half of the investment targets the U.S., with the rest split between Asia Pacific and EMEA, expanding global infrastructure. This move reinforces DHL's role as a key competitor in providing integrated, patient-focused pharmaceutical transportation solutions.

Pharmaceutical Transportation Services Market Report Highlights:

  • Based on type, the biopharmaceuticals segment dominated the market in 2024. The growth of this segment is largely attributed to the rising demand for efficient, secure, and compliant transportation solutions capable of handling biologics, gene therapies, and personalized medications.
  • Based on the services, the air freight segment dominated the market in 2024. The growth of this segment is largely attributed to the increasing demand for rapid delivery of high-value, time-sensitive, and temperature-controlled pharmaceutical products.
  • Based on the supply chain, the non-cold chain logistics segment dominated the market in 2024. The segment's growth is due to the rising demand for medical devices, over the counter (OTC) drugs, and general pharmaceutical distribution.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates and Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Purchased Database
    • 1.3.3. GVR's Internal Database
    • 1.3.4. Secondary Sources
    • 1.3.5. Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Information Analysis
    • 1.4.2. Market Formulation & Data Visualization
    • 1.4.3. Data Validation & Publishing
  • 1.5. Model Details
    • 1.5.1. Commodity Flow Analysis (Model 1)
    • 1.5.2. Top Down Market Estimation (Model 2)
    • 1.5.3. Value-Chain-Based Sizing & Forecasting (Model 3)
    • 1.5.4. Multivariate Analysis (Model 4)
  • 1.6. List of Secondary Sources
  • 1.7. List of Abbreviations
  • 1.8. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Pharmaceutical Transportation Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Demand for Biopharmaceuticals and Specialty Drugs
      • 3.2.1.2. Expansion of Global Pharmaceutical Supply Chain
      • 3.2.1.3. Stringent Regulatory Requirements and Quality Assurance Standards
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Cost of Cold Chain Infrastructure and Maintenance
      • 3.2.2.2. Complex Regulatory and Customs Compliance Across Regions
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Industry Market Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Pharmaceutical Transportation Services Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Pharmaceutical Transportation Services Market Type Movement Analysis
  • 4.3. Global Pharmaceutical Transportation Services Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Biopharmaceuticals
    • 4.4.1. Biopharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Vaccines
      • 4.4.2.1. Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Biosimilars
      • 4.4.3.1. Biosimilars market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Plasma Derived Products
      • 4.4.4.1. Plasma Derived Products market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Pharmaceuticals
    • 4.5.1. Pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pharmaceutical Transportation Services Market: Services Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Pharmaceutical Transportation Services Market Services Movement Analysis
  • 5.3. Global Pharmaceutical Transportation Services Market Size & Trend Analysis, by Services, 2018 to 2030 (USD Million)
  • 5.4. Air Freight
    • 5.4.1. Air Freight market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Sea Freight
    • 5.5.1. Sea Freight market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Overland
    • 5.6.1. Overland market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pharmaceutical Transportation Services Market: Supply Chain Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Pharmaceutical Transportation Services Market Supply Chain Movement Analysis
  • 6.3. Global Pharmaceutical Transportation Services Market Size & Trend Analysis, by Supply Chain, 2018 to 2030 (USD Million)
  • 6.4. Cold Chain Logistics
    • 6.4.1. Cold Chain Logistics market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Non-cold Chain Logistics
    • 6.5.1. Non-cold Chain Logistics market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pharmaceutical Transportation Services Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030 (USD Million)
  • 7.4. North America
    • 7.4.1. North America Market Estimates and Forecasts 2018 to 2030, (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory scenario
      • 7.4.2.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory scenario
      • 7.4.3.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Regulatory scenario
      • 7.4.4.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory scenario
      • 7.5.2.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory scenario
      • 7.5.3.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory scenario
      • 7.5.4.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory scenario
      • 7.5.5.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory scenario
      • 7.5.6.4. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Regulatory scenario
      • 7.5.7.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Competitive scenario
      • 7.5.8.3. Regulatory scenario
      • 7.5.8.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Competitive scenario
      • 7.5.9.3. Regulatory scenario
      • 7.5.9.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory scenario
      • 7.6.2.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory scenario
      • 7.6.3.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory scenario
      • 7.6.4.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory scenario
      • 7.6.5.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory scenario
      • 7.6.6.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory scenario
      • 7.6.7.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory scenario
      • 7.7.2.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory scenario
      • 7.7.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory scenario
      • 7.8.2.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Regulatory scenario
      • 7.8.3.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Regulatory scenario
      • 7.8.4.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Regulatory scenario
      • 7.8.5.4. Israel market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Competition Categorization
  • 8.2. Company Market Share/Assessment Analysis, 2024
  • 8.3. Company Profiles
    • 8.3.1. CEVA Logistics
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Service benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Cencora Corporation (ICS)
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Service benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. DB SCHENKER
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Service benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Kuehne+Nagel
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Service benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Kerry Logistics Network Limited
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Service benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Cardinal Health
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Service benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. FedEx
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Service benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. McKesson Corporation
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Service benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. DHL
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Service benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. EVERSANA
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Service benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Thermo Fisher Scientific
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Service benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Knipper Health
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Service benchmarking
      • 8.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 5 Global pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 6 Global pharmaceutical transportation services Market, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 8 North America pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 9 North America pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 10 U.S. pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 11 U.S. pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 12 U.S. pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 13 Canada pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 Canada pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 15 Canada pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 16 Mexico pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 17 Mexico pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 18 Mexico pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 19 Europe pharmaceutical transportation services Market, by Country, 2018 - 2030 (USD Million)
  • Table 20 Europe pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 21 Europe pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 22 Europe pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 23 Germany pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 24 Germany pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 25 Germany pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 26 UK pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 UK pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 28 UK pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 29 France pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 30 France pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 31 France pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 32 Italy pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 33 Italy pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 34 Italy pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 35 Spain pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 36 Spain pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 37 Spain pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 38 Denmark pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 39 Denmark pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 40 Denmark pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 41 Norway pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 42 Norway pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 43 Norway pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 44 Sweden pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 45 Sweden pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 46 Sweden pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific pharmaceutical transportation services Market, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 51 China pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 52 China pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 53 China pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 54 Japan pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 55 Japan pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 56 Japan pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 57 India pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 58 India pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 59 India pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 60 South Korea pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 61 South Korea pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 62 South Korea pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 63 Australia pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 64 Australia pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 65 Australia pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 66 Thailand pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 67 Thailand pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 68 Thailand pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 69 Latin America pharmaceutical transportation services Market, by Country, 2018 - 2030 (USD Million)
  • Table 70 Latin America pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 71 Latin America pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 72 Latin America pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 73 Brazil pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 74 Brazil pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 75 Brazil pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 76 Argentina pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 77 Argentina pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 78 Argentina pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa pharmaceutical transportation services Market, by Country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 83 South Africa pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 84 South Africa pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 85 South Africa pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 89 UAE pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 90 UAE pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 91 UAE pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 92 Kuwait pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 94 Kuwait pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Pharmaceutical Transportation Services Market Segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot 1
  • Fig. 14 Segment snapshot 2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL by SWOT analysis
  • Fig. 19 Pharmaceutical transportation services market: Type outlook key takeaways
  • Fig. 20 Pharmaceutical transportation services market: Type movement analysis
  • Fig. 21 Biopharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Biosimilars market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Plasma Derived Products market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Pharmaceutical Transportation Services Market: Services outlook key takeaways
  • Fig. 28 Pharmaceutical Transportation Services Market: Services movement analysis
  • Fig. 29 Cold Chain Logistics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Non-cold Chain Logistics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Regional marketplace outlook, 2024 & 2030 (USD Million)
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 North America pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Key country dynamics
  • Fig. 35 U.S. pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Key country dynamics
  • Fig. 37 Canada pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Key country dynamics
  • Fig. 39 Mexico pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 Europe pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 UK regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Germany pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 France pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Italy pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Spain pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Denmark pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Norway pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Sweden pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Japan pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 China pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 India pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Australia pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 South Korea pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Thailand pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Latin America pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Brazil pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Argentina pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 MEA pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 South Africa pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Saudi Arabia pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 UAE pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Kuwait regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Market participant categorization
  • Fig. 87 Precision medicine market share/assessment analysis, 2024
  • Fig. 88 Strategic framework